Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Download:
Coverage Newborn (0-1 years) Children (2-9 years) Mumps Diphtheria Tetanus Pertussis Measles Rubella Poliomyelitis
Administration Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Administration Efficacy/effectiveness Safety Newborn (0-1 years) Hepatitis B Diphtheria Pertussis Tetanus Haemophilus influenzae type B Poliomyelitis
Economic aspects Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Rotavirus
meeting minutes Agenda & Minutes United Kingdom Rotavirus Meningococcal disease Herpes zoster Influenza
Download:
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus